Despite criticisms from the scientific-medical community, health departments, federal regulatory and consumer protection groups; companies funded with tens of millions of dollars from private backers are going forward with plans to create the nation’s largest commercial databank of genetic material and lifestyle and demographic information of employees. To get around the regulatory censures over
